About UsPharmaTher Inc., a wholly-owned subsidiary of Newscope Capital Corporation (CSE: PHRM) (OTCQB: PHRRF), is a specialty life sciences company focused on the research and development of psychedelic pharmaceuticals such as ketamine and psilocybin, for FDA approval to treat mental health, neurological and pain disorders.
|
Corporate Deck (Jan 2021) |
Press ReleasesJanuary 19, 2021
PharmaTher Signs Exclusive Worldwide License Agreement for Patented Ketamine Formulation Targeting Mental Health, Neurological and Pain Disorders January 13, 2021 PharmaTher Approved to Trade on the OTCQB Venture Market December 30, 2020 PharmaTher Announces Application for OTCQB Listing December 21, 2020 PharmaTher Signs LOI to Sell Psilocybin Program to Revive Therapeutics ...more press releases |